BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18209080)

  • 21. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y; Zhou ZH; Ransohoff RM
    J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD; Khan AN; Magner WJ; Tomasi TB
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
    Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
    Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
    Tooze RM; Stephenson S; Doody GM
    J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
    Morris AC; Beresford GW; Mooney MR; Boss JM
    Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
    Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
    J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
    Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
    Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.
    Ito T; Nishiyama C; Nakano N; Nishiyama M; Usui Y; Takeda K; Kanada S; Fukuyama K; Akiba H; Tokura T; Hara M; Tsuboi R; Ogawa H; Okumura K
    Int Immunol; 2009 Jul; 21(7):803-16. PubMed ID: 19502584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription.
    Al-Kandari W; Koneni R; Navalgund V; Aleksandrova A; Jambunathan S; Fontes JD
    J Mol Biol; 2007 Jun; 369(5):1175-87. PubMed ID: 17493635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of interferon-gamma signaling by gene transfer of Stat1 mutant in mesangial cells.
    Sakatsume M; Narita I; Yamazaki H; Saito A; Nakagawa Y; Kuriyama H; Kuwano R; Gejyo F; Arakawa M
    Kidney Int; 2000 Feb; 57(2):455-63. PubMed ID: 10652022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon Regulatory Factors 1 and 2 Play Different Roles in MHC II Expression Mediated by CIITA in Grass Carp,
    Lu XB; Wang ZX; Liu SB; Zhang XY; Lu LF; Li S; Chen DD; Nie P; Zhang YA
    Front Immunol; 2019; 10():1106. PubMed ID: 31191518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
    Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
    J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.
    Cai Q; Banerjee S; Cervini A; Lu J; Hislop AD; Dzeng R; Robertson ES
    PLoS Pathog; 2013 Oct; 9(10):e1003751. PubMed ID: 24204280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.
    Xu Y; Farmer SR; Smith BD
    J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.